Skip to main content
Top
Published in: BMC Immunology 1/2012

Open Access 01-12-2012 | Research article

Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies

Authors: Peng-Cheng Xu, Shen-Ju Gou, Xiao-Wei Yang, Zhao Cui, Xiao-Yu Jia, Min Chen, Ming-Hui Zhao

Published in: BMC Immunology | Issue 1/2012

Login to get access

Abstract

Background

The pathophysiological significance of variable region glycosylation of autoantibodies is still unclear. In the current study, the influence of the variable region N-linked oligosaccharides on the reactivity of three autoantibody specificities was investigated with Sambucus nigra agglutinin (SNA), which mainly binds to oligosaccharides with terminal α2, 6-linked sialic acid on the variable region of IgG.

Methods

Twenty-seven patients with serum positive anti-neutrophil cytoplasmic autoantibodies (ANCA) against myeploperoxidase (MPO) or proteinase 3 (PR3), or autoantibodies against glomerular basement membrane (GBM) were included. Total IgG was isolated and separated into non-SNA-binding and SNA-binding fractions with SNA affinity chromatography. Antigen-specific IgG was purified by immunoaffinity chromatography.

Results

At the same concentration of IgG, the antigen binding level of non-SNA-binding IgG was significantly lower than that of SNA-binding IgG for MPO-ANCA (absorbance value at 405 nm, 0.572 ± 0.590 vs. 0.962 ± 0.670, P < 0.001) and for PR3-ANCA (0.362 ± 0.530 vs. 0.560 ± 0.531, P = 0.003). The antigen binding level of non-SNA-binding IgG was significantly higher than that of SNA-binding IgG for anti-GBM antibodies (1.301 ± 0.594 vs. 1.172 ± 0.583, P = 0.044). The level of variable region glycosylation of total IgG was significantly lower than that of affinity-purified MPO-ANCA (1.021 ± 0.201 vs. 1.434 ± 0.134, P = 0.004). The level of variable region glycosylation of total IgG was significantly higher than that of affinity-purified anti-GBM antibodies (1.034 ± 0.340 vs. 0.734 ± 0.333, P = 0.007). The SNA-binding fraction of MPO-ANCA-containing IgG and PR3-ANCA-containing IgG induced higher levels of neutrophil oxygen radical production than the corresponding non-SNA-binding fractions (P < 0.001 and P = 0.043, respectively). The level of variable region glycosylation of affinity-purified MPO-ANCA was higher in active AAV than the same patients in remission (P = 0.001).

Conclusion

Characteristics of variable region glycosylation of ANCA and anti-GBM antibodies were different from that of total IgG, which might influence the antigen-binding ability of these antibodies. Variable region glycosylation of ANCA might influence the effect of ANCA-induced neutrophils respiratory burst.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med. 1997, 337: 1512-1523. 10.1056/NEJM199711203372106.PubMedCrossRef Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med. 1997, 337: 1512-1523. 10.1056/NEJM199711203372106.PubMedCrossRef
2.
go back to reference Short AK, Esnault VL, Lockwood CM: Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis. 1995, 26: 439-445. 10.1016/0272-6386(95)90489-1.PubMedCrossRef Short AK, Esnault VL, Lockwood CM: Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis. 1995, 26: 439-445. 10.1016/0272-6386(95)90489-1.PubMedCrossRef
3.
go back to reference Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C: Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol. 1997, 8: 376-385.PubMed Hellmark T, Niles JL, Collins AB, McCluskey RT, Brunmark C: Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol. 1997, 8: 376-385.PubMed
4.
go back to reference Parekh RB, Dwek RA, Sutton BJ: Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 1985, 316: 452-457. 10.1038/316452a0.PubMedCrossRef Parekh RB, Dwek RA, Sutton BJ: Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 1985, 316: 452-457. 10.1038/316452a0.PubMedCrossRef
5.
go back to reference Takahashi N, Ishii I, Ishihara H: Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G. Biochemistry. 1987, 26: 1137-1144. 10.1021/bi00378a023.PubMedCrossRef Takahashi N, Ishii I, Ishihara H: Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G. Biochemistry. 1987, 26: 1137-1144. 10.1021/bi00378a023.PubMedCrossRef
6.
go back to reference Holland M, Takada K, Okumoto T: Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Clin Exp Immunol. 2002, 129: 183-190. 10.1046/j.1365-2249.2002.01864.x.PubMedPubMedCentralCrossRef Holland M, Takada K, Okumoto T: Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Clin Exp Immunol. 2002, 129: 183-190. 10.1046/j.1365-2249.2002.01864.x.PubMedPubMedCentralCrossRef
7.
go back to reference Espy C, Morelle W, Kavian N: Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's). Arthritis Rheum. 2011, 63: 2105-2115. 10.1002/art.30362.PubMedCrossRef Espy C, Morelle W, Kavian N: Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's). Arthritis Rheum. 2011, 63: 2105-2115. 10.1002/art.30362.PubMedCrossRef
8.
go back to reference Donadel G, Calabro A, Sigounas G: Human polyreactive and monoreactive antibodies: effect of glycosylation on antigen binding. Glycobiology. 1994, 4: 491-496. 10.1093/glycob/4.4.491.PubMedCrossRef Donadel G, Calabro A, Sigounas G: Human polyreactive and monoreactive antibodies: effect of glycosylation on antigen binding. Glycobiology. 1994, 4: 491-496. 10.1093/glycob/4.4.491.PubMedCrossRef
9.
go back to reference Rudd PM, Leatherbarrow RJ, Rademacher TW, Dwek RA: Diversification of the IgG molecule by oligosaccharides. Mol Immunol. 1991, 28: 1369-1378. 10.1016/0161-5890(91)90039-M.PubMedCrossRef Rudd PM, Leatherbarrow RJ, Rademacher TW, Dwek RA: Diversification of the IgG molecule by oligosaccharides. Mol Immunol. 1991, 28: 1369-1378. 10.1016/0161-5890(91)90039-M.PubMedCrossRef
10.
go back to reference Huang L, Biolsi S, Bales KR, Kuchibhotla U: Impact of variable domain glycosylation on antibody clearance: an LC/MS characterization. Anal Biochem. 2006, 349: 197-207. 10.1016/j.ab.2005.11.012.PubMedCrossRef Huang L, Biolsi S, Bales KR, Kuchibhotla U: Impact of variable domain glycosylation on antibody clearance: an LC/MS characterization. Anal Biochem. 2006, 349: 197-207. 10.1016/j.ab.2005.11.012.PubMedCrossRef
11.
go back to reference Malhotra R, Wormald MR, Rudd PM: Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med. 1995, 1: 237-243. 10.1038/nm0395-237.PubMedCrossRef Malhotra R, Wormald MR, Rudd PM: Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med. 1995, 1: 237-243. 10.1038/nm0395-237.PubMedCrossRef
12.
go back to reference van Timmeren MM, van der Veen BS, Stegeman CA: IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. J Am Soc Nephrol. 2010, 21: 1103-1114. 10.1681/ASN.2009090984.PubMedPubMedCentralCrossRef van Timmeren MM, van der Veen BS, Stegeman CA: IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. J Am Soc Nephrol. 2010, 21: 1103-1114. 10.1681/ASN.2009090984.PubMedPubMedCentralCrossRef
13.
go back to reference Kusakabe K, Kanaya K, Sato S, Kato M, Mochizuki K: Accumulation enhancement of human monoclonal antibody HB4C5 to lung tumor xenografts by N-deglycosylation. J Nucl Med. 1994, 35: 289-295.PubMed Kusakabe K, Kanaya K, Sato S, Kato M, Mochizuki K: Accumulation enhancement of human monoclonal antibody HB4C5 to lung tumor xenografts by N-deglycosylation. J Nucl Med. 1994, 35: 289-295.PubMed
14.
go back to reference Co MS, Scheinberg DA, Avdalovic NM: Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody. Mol Immunol. 1993, 30: 1361-1367. 10.1016/0161-5890(93)90097-U.PubMedCrossRef Co MS, Scheinberg DA, Avdalovic NM: Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody. Mol Immunol. 1993, 30: 1361-1367. 10.1016/0161-5890(93)90097-U.PubMedCrossRef
15.
go back to reference Kato M, Mochizuki K, Hashizume S: Activity enhancement of a lung cancer-associated human monoclonal antibody HB4C5 by N-deglycosylation. Hum Antibodies Hybridomas. 1993, 4: 9-14.PubMed Kato M, Mochizuki K, Hashizume S: Activity enhancement of a lung cancer-associated human monoclonal antibody HB4C5 by N-deglycosylation. Hum Antibodies Hybridomas. 1993, 4: 9-14.PubMed
16.
go back to reference Matsuuchi L, Sharon J, Morrison SL: An analysis of heavy chain glycopeptides of hybridoma antibodies: correlation between antibody specificity and sialic acid content. J Immunol. 1981, 127: 2188-2190.PubMed Matsuuchi L, Sharon J, Morrison SL: An analysis of heavy chain glycopeptides of hybridoma antibodies: correlation between antibody specificity and sialic acid content. J Immunol. 1981, 127: 2188-2190.PubMed
17.
go back to reference Tachibana H, Shirahata S, Murakami H: Generation of specificity-variant antibodies by alteration of carbohydrate in light chain of human monoclonal antibodies. Biochem Biophys Res Commun. 1992, 189: 625-632. 10.1016/0006-291X(92)92246-T.PubMedCrossRef Tachibana H, Shirahata S, Murakami H: Generation of specificity-variant antibodies by alteration of carbohydrate in light chain of human monoclonal antibodies. Biochem Biophys Res Commun. 1992, 189: 625-632. 10.1016/0006-291X(92)92246-T.PubMedCrossRef
18.
go back to reference Coloma MJ, Trinh RK, Martinez AR, Morrison SL: Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1- > 6) dextran antibody. J Immunol. 1999, 162: 2162-2170.PubMed Coloma MJ, Trinh RK, Martinez AR, Morrison SL: Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1- > 6) dextran antibody. J Immunol. 1999, 162: 2162-2170.PubMed
19.
go back to reference Shibuya N, Goldstein IJ, Broekaert WF: The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J Biol Chem. 1987, 262: 1596-1601.PubMed Shibuya N, Goldstein IJ, Broekaert WF: The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J Biol Chem. 1987, 262: 1596-1601.PubMed
20.
go back to reference Stadlmann J, Weber A, Pabst M: A close look at human IgG sialylation and subclass distribution after lectin fractionation. Proteomics. 2009, 9: 4143-4153. 10.1002/pmic.200800931.PubMedCrossRef Stadlmann J, Weber A, Pabst M: A close look at human IgG sialylation and subclass distribution after lectin fractionation. Proteomics. 2009, 9: 4143-4153. 10.1002/pmic.200800931.PubMedCrossRef
21.
go back to reference Dalziel M, McFarlane I, Axford JS: Lectin analysis of human immunoglobulin G N-glycan sialylation. Glycoconj J. 1999, 16: 801-807. 10.1023/A:1007183915921.PubMedCrossRef Dalziel M, McFarlane I, Axford JS: Lectin analysis of human immunoglobulin G N-glycan sialylation. Glycoconj J. 1999, 16: 801-807. 10.1023/A:1007183915921.PubMedCrossRef
22.
go back to reference Rademacher TW: Network theory of glycosylation-etiologic and pathogenic implications of changes in IgG glycoform levels in autoimmunity. Semin Cell Biol. 1991, 2: 327-337.PubMed Rademacher TW: Network theory of glycosylation-etiologic and pathogenic implications of changes in IgG glycoform levels in autoimmunity. Semin Cell Biol. 1991, 2: 327-337.PubMed
23.
go back to reference Holland M, Yagi H, Takahashi N: Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim Biophys Acta. 2006, 1760: 669-677. 10.1016/j.bbagen.2005.11.021.PubMedCrossRef Holland M, Yagi H, Takahashi N: Differential glycosylation of polyclonal IgG, IgG-Fc and IgG-Fab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim Biophys Acta. 2006, 1760: 669-677. 10.1016/j.bbagen.2005.11.021.PubMedCrossRef
24.
go back to reference Guhr T, Bloem J, Derksen NI: Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia. PLoS One. 2011, 6: e21246-10.1371/journal.pone.0021246.PubMedPubMedCentralCrossRef Guhr T, Bloem J, Derksen NI: Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia. PLoS One. 2011, 6: e21246-10.1371/journal.pone.0021246.PubMedPubMedCentralCrossRef
25.
go back to reference Endo T, Wright A, Morrison SL, Kobata A: Glycosylation of the variable region of immunoglobulin G--site specific maturation of the sugar chains. Mol Immunol. 1995, 32: 931-940. 10.1016/0161-5890(95)00078-S.PubMedCrossRef Endo T, Wright A, Morrison SL, Kobata A: Glycosylation of the variable region of immunoglobulin G--site specific maturation of the sugar chains. Mol Immunol. 1995, 32: 931-940. 10.1016/0161-5890(95)00078-S.PubMedCrossRef
26.
go back to reference Kinoshita N, Ohno M, Nishiura T: Glycosylation at the Fab portion of myeloma immunoglobulin G and increased fucosylated biantennary sugar chains: structural analysis by high-performance liquid chromatography and antibody-lectin enzyme immunoassay using Lens culinaris agglutinin. Cancer Res. 1991, 51: 5888-5892.PubMed Kinoshita N, Ohno M, Nishiura T: Glycosylation at the Fab portion of myeloma immunoglobulin G and increased fucosylated biantennary sugar chains: structural analysis by high-performance liquid chromatography and antibody-lectin enzyme immunoassay using Lens culinaris agglutinin. Cancer Res. 1991, 51: 5888-5892.PubMed
27.
go back to reference Jennette JC, Falk RJ, Andrassy K: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994, 37: 187-192. 10.1002/art.1780370206.PubMedCrossRef Jennette JC, Falk RJ, Andrassy K: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994, 37: 187-192. 10.1002/art.1780370206.PubMedCrossRef
28.
go back to reference Zhao MH, Lockwood CM: A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Methods. 1996, 197: 121-130. 10.1016/0022-1759(96)00123-8.PubMedCrossRef Zhao MH, Lockwood CM: A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Methods. 1996, 197: 121-130. 10.1016/0022-1759(96)00123-8.PubMedCrossRef
29.
go back to reference Cui Z, Zhao MH, Xin G, Wang HY: Characteristics and Prognosis of Chinese Patients with Anti-Glomerular Basement Membrane Disease. Nephron Clin Pract. 2005, 99: c49-c55. 10.1159/000083133.PubMedCrossRef Cui Z, Zhao MH, Xin G, Wang HY: Characteristics and Prognosis of Chinese Patients with Anti-Glomerular Basement Membrane Disease. Nephron Clin Pract. 2005, 99: c49-c55. 10.1159/000083133.PubMedCrossRef
30.
go back to reference Franco Fraguas L, Carlsson J, Lönnberg M: Lectin affinity chromatography as a tool to differentiate endogenous and recombinant erythropoietins. J Chromatogr A. 2008, 1212: 82-88. 10.1016/j.chroma.2008.10.036.PubMedCrossRef Franco Fraguas L, Carlsson J, Lönnberg M: Lectin affinity chromatography as a tool to differentiate endogenous and recombinant erythropoietins. J Chromatogr A. 2008, 1212: 82-88. 10.1016/j.chroma.2008.10.036.PubMedCrossRef
31.
go back to reference Mimura Y, Ashton PR, Takahashi N, Harvey DJ, Jefferis R: Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry. J Immunol Methods. 2007, 326: 116-126. 10.1016/j.jim.2007.07.014.PubMedCrossRef Mimura Y, Ashton PR, Takahashi N, Harvey DJ, Jefferis R: Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry. J Immunol Methods. 2007, 326: 116-126. 10.1016/j.jim.2007.07.014.PubMedCrossRef
32.
go back to reference Xu PC, Chen M, Cui Z, Zhao MH: Influence of myeloperoxidase by anti-myeloperoxidase antibodies and its association with the disease activity in microscopic polyangiitis. Rheumatology (Oxford). 2010, 49: 2068-2075. 10.1093/rheumatology/keq203.CrossRef Xu PC, Chen M, Cui Z, Zhao MH: Influence of myeloperoxidase by anti-myeloperoxidase antibodies and its association with the disease activity in microscopic polyangiitis. Rheumatology (Oxford). 2010, 49: 2068-2075. 10.1093/rheumatology/keq203.CrossRef
33.
go back to reference Kettritz R, Schreiber A, Luft FC, Haller H: Role of mitogen-activated protein kinases in activation of human neutrophils by antineutrophil cytoplasmic antibodies. J Am Soc Nephrol. 2001, 12: 37-46.PubMed Kettritz R, Schreiber A, Luft FC, Haller H: Role of mitogen-activated protein kinases in activation of human neutrophils by antineutrophil cytoplasmic antibodies. J Am Soc Nephrol. 2001, 12: 37-46.PubMed
34.
go back to reference Borza DB, Netzer KO, Leinonen A: The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem. 2000, 275: 6030-6037. 10.1074/jbc.275.8.6030.PubMedCrossRef Borza DB, Netzer KO, Leinonen A: The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain. J Biol Chem. 2000, 275: 6030-6037. 10.1074/jbc.275.8.6030.PubMedCrossRef
35.
go back to reference Yang R, Hellmark T, Zhao J: Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol. 2007, 18: 1338-1343. 10.1681/ASN.2006111210.PubMedCrossRef Yang R, Hellmark T, Zhao J: Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol. 2007, 18: 1338-1343. 10.1681/ASN.2006111210.PubMedCrossRef
36.
go back to reference Luqmani RA, Bacon PA, Moots RJ: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994, 87: 671-678.PubMed Luqmani RA, Bacon PA, Moots RJ: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994, 87: 671-678.PubMed
37.
go back to reference Zhang Z, Pan H, Chen X: Mass spectrometry for structural characterization of therapeutic antibodies. Mass Spectrom Rev. 2009, 28: 147-176. 10.1002/mas.20190.PubMedCrossRef Zhang Z, Pan H, Chen X: Mass spectrometry for structural characterization of therapeutic antibodies. Mass Spectrom Rev. 2009, 28: 147-176. 10.1002/mas.20190.PubMedCrossRef
38.
go back to reference Zhu D, McCarthy H, Ottensmeier CH: Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood. 2002, 99: 2562-2568. 10.1182/blood.V99.7.2562.PubMedCrossRef Zhu D, McCarthy H, Ottensmeier CH: Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood. 2002, 99: 2562-2568. 10.1182/blood.V99.7.2562.PubMedCrossRef
39.
go back to reference Derry CJ, Dunn MJ, Rees AJ, Pusey CD: Restricted specificity of the autoantibody response in Goodpasture's syndrome demonstrated by two-dimensional western blotting. Clin Exp Immunol. 1991, 86: 457-463. 10.1111/j.1365-2249.1991.tb02953.x.PubMedPubMedCentralCrossRef Derry CJ, Dunn MJ, Rees AJ, Pusey CD: Restricted specificity of the autoantibody response in Goodpasture's syndrome demonstrated by two-dimensional western blotting. Clin Exp Immunol. 1991, 86: 457-463. 10.1111/j.1365-2249.1991.tb02953.x.PubMedPubMedCentralCrossRef
40.
go back to reference Malle E, Buch T, Grone HJ: Myeloperoxidase in kidney disease. Kidney Int. 2003, 64: 1956-1967. 10.1046/j.1523-1755.2003.00336.x.PubMedCrossRef Malle E, Buch T, Grone HJ: Myeloperoxidase in kidney disease. Kidney Int. 2003, 64: 1956-1967. 10.1046/j.1523-1755.2003.00336.x.PubMedCrossRef
41.
go back to reference Franssen CF, Stegeman CA, Kallenberg CG: Antiproteinase 3-and antimyeloperoxidase-associated vasculitis. Kidney Int. 2000, 57: 2195-2206. 10.1046/j.1523-1755.2000.00080.x.PubMedCrossRef Franssen CF, Stegeman CA, Kallenberg CG: Antiproteinase 3-and antimyeloperoxidase-associated vasculitis. Kidney Int. 2000, 57: 2195-2206. 10.1046/j.1523-1755.2000.00080.x.PubMedCrossRef
42.
go back to reference Gala FA, Morrison SL: V region carbohydrate and antibody expression. J Immunol. 2004, 172: 5489-5494.PubMedCrossRef Gala FA, Morrison SL: V region carbohydrate and antibody expression. J Immunol. 2004, 172: 5489-5494.PubMedCrossRef
43.
go back to reference Berek C: The development of B cells and the B-cell repertoire in the microenvironment of the germinal center. Immunol Rev. 1992, 126: 5-19. 10.1111/j.1600-065X.1992.tb00628.x.PubMedCrossRef Berek C: The development of B cells and the B-cell repertoire in the microenvironment of the germinal center. Immunol Rev. 1992, 126: 5-19. 10.1111/j.1600-065X.1992.tb00628.x.PubMedCrossRef
44.
go back to reference Tomlinson IM, Walter G, Jones PT: The imprint of somatic hypermutation on the repertoire of human germline V genes. J Mol Biol. 1996, 256: 813-817. 10.1006/jmbi.1996.0127.PubMedCrossRef Tomlinson IM, Walter G, Jones PT: The imprint of somatic hypermutation on the repertoire of human germline V genes. J Mol Biol. 1996, 256: 813-817. 10.1006/jmbi.1996.0127.PubMedCrossRef
45.
go back to reference Cox JP, Tomlinson IM, Winter G: A directory of human germ-line V kappa segments reveals a strong bias in their usage. Eur J Immunol. 1994, 24: 827-836. 10.1002/eji.1830240409.PubMedCrossRef Cox JP, Tomlinson IM, Winter G: A directory of human germ-line V kappa segments reveals a strong bias in their usage. Eur J Immunol. 1994, 24: 827-836. 10.1002/eji.1830240409.PubMedCrossRef
46.
go back to reference Walter G, Tomlinson IM, Dear PH: Comparison of the human germline and rearranged VH repertoire reveals complementarity between germline variability and somatic mutation. Ann N Y Acad Sci. 1995, 764: 180-182.PubMedCrossRef Walter G, Tomlinson IM, Dear PH: Comparison of the human germline and rearranged VH repertoire reveals complementarity between germline variability and somatic mutation. Ann N Y Acad Sci. 1995, 764: 180-182.PubMedCrossRef
47.
go back to reference Dunn-Walters D, Boursier L, Spencer J: Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions. Mol Immunol. 2000, 37: 107-113. 10.1016/S0161-5890(00)00038-9.PubMedCrossRef Dunn-Walters D, Boursier L, Spencer J: Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions. Mol Immunol. 2000, 37: 107-113. 10.1016/S0161-5890(00)00038-9.PubMedCrossRef
Metadata
Title
Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies
Authors
Peng-Cheng Xu
Shen-Ju Gou
Xiao-Wei Yang
Zhao Cui
Xiao-Yu Jia
Min Chen
Ming-Hui Zhao
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2012
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-13-10

Other articles of this Issue 1/2012

BMC Immunology 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.